Literature DB >> 4548387

Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.

V B Sinha, K Bhaskaran.   

Abstract

The protection conferred by parenteral cholera vaccines and cholera toxoid was determined in the rabbit ileal loop model of experimental cholera. Vibrio cholerae strains belonging to two different serotypes were employed, for immunization and challenge, to differentiate antibacterial and antitoxic immunity patterns. It was found that vaccines were protective but cholera toxoid was not, although serum antitoxin levels were high after administration of the latter. Antibacterial immunity was strictly serotype-specific, with evidence of cross-protection only between Ogawa and Inaba subtypes of serotype 1. Bivalent serotype 1 vaccines conferred protection against homologous challenge strains but immunity to Inaba infection was of shorter duration than immunity to Ogawa infection.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4548387      PMCID: PMC2481025     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Experimental cholera in infant rabbits: a method for chemotherapeutic investigation.

Authors:  N K DUTTA; M K HABBU
Journal:  Br J Pharmacol Chemother       Date:  1955-06

2.  Titration of cholera antitoxin levels by passive hemagglutination tests using fresh and formalinized sheep erythrocytes.

Authors:  H D Hochstein; J C Feeley; S H Richardson
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

3.  The titration of cholera toxin and antitoxin in the rabbit ileal loop.

Authors:  G J Kasai; W Burrows
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

4.  Monospecific equine antiserum against cholera exo-enterotoxin.

Authors:  R A Finkelstein
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

5.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.